3-(2-氨基乙基)-1,3-噻唑烷-2,4-二酮盐酸盐 | 39137-36-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑烷类
• 中文名称: 3-(2-氨基乙基)-1,3-噻唑烷-2,4-二酮盐酸盐
• 英文名称: 3-<2-Amino-ethyl>-thiazolidin-2.4-dion
• 英文别名: 3-(β-Aminoethyl)-2.4-thiazolidin-dion；3-(2-aminoethyl)-1,3-thiazolidine-2,4-dione；3-(2-amino-ethyl)-thiazolidine-2,4-dione；3-(2-Amino-aethyl)-thiazolidin-2,4-dion
• CAS: 39137-36-5
• 化学式: C₅H₈N₂O₂S
• mdl: MFCD01026817
• 分子量: 160.197
• InChiKey: PSJIYWXYXJTRRY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.7
• 重原子数：
  10
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  88.7
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 海关编码：
  2934999090

反应信息

• 作为反应物：
  描述：

  3-(2-氨基乙基)-1,3-噻唑烷-2,4-二酮盐酸盐 、 2,4,6-三氯喹唑啉 在 N,N-二异丙基乙胺 作用下， 以 乙酸乙酯 为溶剂， 生成 3-[2-[(2,6-Dichloroquinazolin-4-yl)amino]ethyl]-1,3-thiazolidine-2,4-dione
  参考文献：
  名称：

  Synthesis and QSAR of Quinazoline Sulfonamides As Highly Potent Human Histamine H₄ Receptor Inverse Agonists

  摘要：

  Hit optimization of the class of quinazoline containing histamine H-4 receptor (H4R) ligands resulted in a sulfonamide substituted analogue with high affinity for the H4R. This moiety leads to improved physicochemical properties and is believed to probe a distinct H4R binding pocket that was previously identified using pharmacophore modeling. By introducing a variety of sulfonamide substituents, the H4R affinity was optimized. The interaction of the new ligands, in combination with a set of previously published quinazoline compounds, was described by a QSAR equation. Pharmacological studies revealed that the sulfonamide analogues have excellent H4R affinity and behave as inverse agonists at the human H4R. In vivo evaluation of the potent 2-(6-chloro-2-(4-methylpiperazin-1-yl)quinazoline-4-amino)-N-phenylethanesulfonamide (54) (pK(i) = 8.31 +/- 0.10) revealed it to have anti-inflammatory activity in an animal model of acute inflammation.

  DOI：

  10.1021/jm901379s
• 作为产物：
  描述：

  2-((4,5-dihydro-1H-imidazol-2-yl)thio)acetic acid 在 盐酸 作用下， 以 乙醇 为溶剂， 生成 3-(2-氨基乙基)-1,3-噻唑烷-2,4-二酮盐酸盐
  参考文献：
  名称：

  Reactions of Ethylenethiourea with α- and β-Halo Acids and Derivatives¹

  摘要：

  DOI：

  10.1021/jo01030a013

文献信息

• SUBSTITUTED PYRIDONES AS INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE (PARP)
  申请人：Weintraub M. Philip

  公开号：US20070032489A1

  公开（公告）日：2007-02-08

  The present invention relates to a series of 2,3,5-substituted pyridone derivatives of formula I: wherein R, R 1 , R 2 , R 3 and R 4 are as defined herein. This invention also relates to methods of making these compounds. The compounds of this invention are inhibitors of poly(adenosine 5′-diphosphate ribose) polymerase (PARP) and are therefore useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of diseases, including diseases associated with the central nervous system and cardiovascular disorders.

  本发明涉及一系列公式I的2,3,5-取代吡啶酮衍生物，其中R，R1，R2，R3和R4如本文所定义。本发明还涉及制备这些化合物的方法。本发明的化合物是聚腺苷酸二磷酸核糖聚合酶（PARP）的抑制剂，因此在治疗和/或预防各种疾病，包括与中枢神经系统和心血管疾病有关的疾病方面，具有药物学上的用途。
• Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP)
  申请人：Aventis Pharmaceuticals Inc.

  公开号：US08173682B2

  公开（公告）日：2012-05-08

  The present invention relates to a series of 2,3,5-substituted pyridone derivatives of formula I: wherein R, R1, R2, R3 and R4 are as defined herein. This invention also relates to methods of making these compounds. The compounds of this invention are inhibitors of poly(adenosine 5′-diphosphate ribose) polymerase (PARP) and are therefore useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of diseases, including diseases associated with the central nervous system and cardiovascular disorders.

  本发明涉及一系列式I的2,3,5-取代吡啶酮衍生物，其中R、R1、R2、R3和R4如本文所定义。本发明还涉及制备这些化合物的方法。本发明的化合物是聚腺苷酸二磷酸核糖聚合酶（PARP）的抑制剂，因此在医药领域中具有广泛的应用，特别是在治疗和/或预防多种疾病，包括与中枢神经系统和心血管疾病相关的疾病方面。
• Radical chlorination of non-resonant heterobenzylic C‒H bonds and high-throughput diversification of heterocycles
  作者：Dung L. Golden、Kaitlyn M. Flynn、Santeri Aikonen、Christopher M. Hanneman、Dipannita Kalyani、Shane W. Krska、Robert S. Paton、Shannon S. Stahl

  DOI：10.1016/j.chempr.2024.04.001

  日期：2024.4

  Site-selective functionalization of the heterobenzylic C(sp)–H bonds of pyridines and related heteroaromatic compounds presents challenges associated with the basic nitrogen atom and the variable reactivity among different positions on the heteroaromatic ring. Methods for functionalization of 2- and 4-alkylpyridines are increasingly available through polar pathways that leverage resonance stabilization

  吡啶和相关杂芳族化合物的杂苄基 C(sp)-H 键的位点选择性官能化提出了与碱性氮原子和杂芳环上不同位置之间的可变反应性相关的挑战。 2-和4-烷基吡啶的功能化方法越来越多地通过利用这些位置上电荷积累的共振稳定性的极性途径来实现。相比之下，3-烷基吡啶的官能化基本上是难以实现的。在这里，我们报道了一种光化学促进的方法，用于 3-烷基吡啶和相关烷基杂芳烃中非共振杂苄基 C(sp)-H 位点的氯化。密度泛函理论计算表明，最佳反应性反映了两个自由基链增长步骤的能量之间的平衡，优选试剂由β-氯磺酰胺组成。操作简单的氯化方案能够获得杂苄基氯化物，它可作为杂芳族结构单元和各种氧化敏感亲核试剂之间的 C-H 交叉偶联反应的多功能中间体，通过高通量实验进行。
• 314. Structure and antimalarial activity. Part IV. Benziminazoles and mercaptodihydroglyoxalines
  作者：A. T. James、E. E. Turner

  DOI：10.1039/jr9500001515

  日期：——
• The Rearrangement of 2-Carboxymethylmercaptoimidazolidine
  作者：JAMES A. VanALLAN

  DOI：10.1021/jo01108a011

  日期：1956.2